Egypt Pharma Serialization: Track & Trace Timeline and Market Insights (2026)

Earlier this month, the Egyptian Drug Authority officially announced in the Official Gazette the launch of Egypt’s unified national electronic system for pharmaceutical Track & Trace.

• Imported & manufactured finished products – Registration begins February 2026
• Locally produced or packed products – Registration begins August 2026

This rollout marks a turning point for Egypt’s pharmaceutical sector, which is already the largest in Africa.

Below is an overview of the current market and supply chain structure, and what the new regulation means for Marketing Authorization Holders (MAHs) and manufacturers.

Manufacturing – Egypt’s Strong Local Backbone

Egypt has one of the most localized pharmaceutical markets in the region, with 91% of products manufactured domestically:

 

• 179 factories
• 2,370 production lines
• 1,600+ distribution companies
• 80,000 pharmacies

 

This localized strength means compliance will depend on the ability of both large and mid-sized manufacturers to quickly align their systems with the new Track & Trace requirements.

 

 

Supply Chain Dynamics

The Egyptian pharmaceutical supply chain flows from MAHs and manufacturers to wholesalers, distributors, and finally to the retail sector.

 

 

Market Snapshot

 

• 12,000+ registered drug products
• 3.5 billion units sold annually – soon to become serialized packs under Track & Trace
• 82,000+ GLNs already active across the ecosystem
• USD 6.2 billion market size – officially Africa’s largest pharmaceutical market

If you are MAH in Egypt, now is the time to:

We’ve seen it in every market: companies that start early avoid panic, extra costs, and compliance risks.

SoftGroup’s SATT PLATFORM will be ready to connect to Egypt’s national system from day one, covering:

With proven experience across the EU, MENA, CIS, and beyond, SoftGroup helps pharmaceutical companies maintain compliance, reduce risk, and keep production running smoothly.